Sanofi 54 andGlaxoSmithKline (GSK) two of the largest vaccine manufacturers in the world, have just introduced a new vaccine of Covid- 19 that they say is much easier to store, therefore, has the ability to help vaccinate the larger global population. there are two types of vaccines, type A and type B can be made to prepare the global population. The vaccines must be injected in humans before they catch covid 19 in order to be effective, and each type of vaccine is unique it takes the company six months to produce each vaccine, but they do not know which type will be more effective because the virus could adapt with more new types, so they plan to produce and keep inventory of 50% of type a and 50% of type b. The Key ingredient for the vaccine is a plant called 'Star Anise', it is only found in the remote mountains of east Asia and mined by one company. Although it is always available for purchase from one supplier, it is expensive to procure.

Q- Which sourcing strategy category would you place the procurement of Star Anise for Sanofi/ GSK

1. Bottleneck

2. Strategic

3. Noncritical

4. Leverage